NK
NKGen Biotech, Inc. Warrants
NKGNW · NASDAQ
$0.03 +2,408.33% (+$0.03)
Market Cap $6.18M
P/E Ratio -
Div. Yield -
ROE 103.10%
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 9.48x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 0.00%
Net margin 6,792.33%
Op. margin 4,135.89%
Quality
75 /100
Excellent ROE 103.10%
ROA 184,525.00%
Asset turnover 27.17x
Debt
64 /100
Moderate Int. coverage 0.00x
Net debt/EBITDA 0.00x
Debt/Equity N/A
Stability
37 /100
Moderate Beta 0.64x
EPS volatility 211.35%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NKGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Y. Song
Employees
63
Headquarters
Santa Ana